Propel Bio Management’s X4 Pharmaceuticals XFOR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,833	Closed	-$744K	–	31
2024 Q1	$744K	Hold	17,833	–	–	0.43%	23
2023 Q4	$449K	Buy	+17,833	New	+$449K	0.37%	29